Our Science
The past decade has seen significant interest in the microbiome. It is now clearly established that a healthy gut microbiota is paramount to general health, with implications across a wide range of diseases.
Prevatex has licensed a suite of intellectual property covering a link between bacteria in the maternal and infant microbiomes and the risk of infants developing both food allergies and behavioural concerns in the first years of life. We are also exploring opportunities in animal health – an exciting new development.
The articles below provide insight into our research – and related studies – showing the benefits of a healthy Prevotella-based gut microbiome.
Carriage of Prevotella by pregnant mothers protects against food allergy in the child at one year of age – data from the Barwon Infant Study
Click through to view the publications.
Abundance of Prevotella in the gut microbiota is associated with reduced allergy – data from other studies
Click through to view the publications.
The abundance of Prevotella in the gut microbiota is associated with improved cardio-metabolic health – data from large population-based studies
Click through to view the publications.